Echoiq Limited has released a press release.
Quarterly Activities and Appendix 4C Cash Flow Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from EchoIQ
- Category III CPT code application update
- Trading Halt
- Pause in Trading
- Strong Operational Momentum
- Update on Category III CPT Code Application
Later from EchoIQ
- Echo IQ Highlights Market Potential for EchoSolv AS Following Presentation of New Data for Severe Aortic Stenosis (AS) Presented at AHA Scientific Sessions 2025
- Echo IQ to Participate in the Piper Sandler 37th Annual Healthcare Conference
- Exceptional Results from Validation Study for EchoSolv HF
- Validation study for EchoSolv HF completed at the Mayo Clinic – Study delivers exceptional results
- Echo IQ to Present at the Life Sciences Virtual Investor Forum on 11th December
Follow EchoIQ into a list and get an email when it puts out news.
Follow EchoIQ